Addus HomeCare (NASDAQ:ADUS) Stock Rating Lowered by Barclays

Addus HomeCare (NASDAQ:ADUS) was downgraded by equities research analysts at Barclays from an “equal weight” rating to an “underweight” rating in a research note issued to investors on Tuesday, Marketbeat.com reports. They currently have a $83.00 price target on the stock. Barclays‘s price objective would suggest a potential downside of 13.09% from the company’s previous close.

A number of other equities research analysts have also recently issued reports on the company. William Blair reaffirmed an “outperform” rating on shares of Addus HomeCare in a research report on Monday, February 5th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $102.00 target price on shares of Addus HomeCare in a research report on Thursday, February 29th. Finally, Oppenheimer reaffirmed an “outperform” rating and set a $118.00 target price on shares of Addus HomeCare in a research report on Tuesday, March 26th. One equities research analyst has rated the stock with a sell rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, Addus HomeCare currently has a consensus rating of “Moderate Buy” and an average price target of $103.00.

Addus HomeCare Price Performance

Shares of ADUS opened at $95.50 on Tuesday. The company has a market capitalization of $1.55 billion, a price-to-earnings ratio of 24.87, a P/E/G ratio of 1.84 and a beta of 0.96. Addus HomeCare has a fifty-two week low of $77.30 and a fifty-two week high of $114.97. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.38 and a quick ratio of 1.38. The business’s 50-day moving average is $97.66 and its 200-day moving average is $91.56.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, February 26th. The company reported $1.21 earnings per share for the quarter, beating analysts’ consensus estimates of $1.04 by $0.17. The company had revenue of $276.35 million for the quarter, compared to the consensus estimate of $274.02 million. Addus HomeCare had a return on equity of 9.70% and a net margin of 5.91%. Equities research analysts expect that Addus HomeCare will post 4.38 EPS for the current fiscal year.

Institutional Investors Weigh In On Addus HomeCare

Several hedge funds have recently modified their holdings of the business. Vanguard Group Inc. boosted its position in shares of Addus HomeCare by 3.2% in the fourth quarter. Vanguard Group Inc. now owns 1,257,440 shares of the company’s stock valued at $116,753,000 after acquiring an additional 38,876 shares during the period. Wellington Management Group LLP boosted its position in shares of Addus HomeCare by 1.2% in the fourth quarter. Wellington Management Group LLP now owns 798,435 shares of the company’s stock valued at $74,135,000 after acquiring an additional 9,548 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of Addus HomeCare by 0.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 698,498 shares of the company’s stock valued at $64,857,000 after acquiring an additional 5,654 shares during the period. Summit Creek Advisors LLC boosted its position in shares of Addus HomeCare by 14.5% in the third quarter. Summit Creek Advisors LLC now owns 288,158 shares of the company’s stock valued at $24,548,000 after acquiring an additional 36,578 shares during the period. Finally, TimesSquare Capital Management LLC boosted its position in shares of Addus HomeCare by 13.0% in the fourth quarter. TimesSquare Capital Management LLC now owns 264,088 shares of the company’s stock valued at $24,521,000 after acquiring an additional 30,330 shares during the period. 95.35% of the stock is owned by institutional investors.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.